Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.

scientific article published on 20 June 2013

Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.SCHRES.2013.05.024
P698PubMed publication ID23791389

P50authorMatcheri S KeshavanQ48067656
P2093author name stringJeffrey A Stanley
Ian T Mathew
Neeraj Tandon
Alan N Francis
Nicolas R Bolo
Kunal Sanghavi
P2860cites workNeuroanatomical differences between familial and sporadic schizophrenia and their parents: an optimized voxel-based morphometry studyQ48788575
In vivo nuclear magnetic resonance chemical shift imaging by selective irradiationQ36615804
P433issue1-3
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
P304page(s)59-66
P577publication date2013-06-20
P1433published inSchizophrenia ResearchQ7431607
P1476titleBrain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
P478volume148

Reverse relations

cites work (P2860)
Q495514617T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Q35925913Altered Cortico-Striatal Connectivity in Offspring of Schizophrenia Patients Relative to Offspring of Bipolar Patients and Controls
Q47627875Clinical psychopathology in youth at familial high risk for psychosis
Q92536208Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research
Q30993265Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy
Q48647261Differences in Metabolite Concentrations Between the Hemispheres of the Brain in Healthy Children: A Proton Magnetic Resonance Spectroscopy Study (1HMRS).
Q38495807Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions.
Q57496453Effect of Adjuvant Electroconvulsive Therapy Compared to Antipsychotic Medication Alone on the Brain Metabolites of Patients with Chronic Schizophrenia: A Proton Magnetic Resonance Spectroscopy Study
Q36992322Glutamate and dopamine in schizophrenia: an update for the 21st century
Q48343342Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum
Q30845062Glutamate-mediated excitotoxicity in schizophrenia: a review
Q60242669Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study
Q57291671Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a [H]-spectroscopy twin study
Q36813471Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis
Q30854782Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation
Q31137179Metabolic Imaging in Humans
Q33942094Recent advances in understanding schizophrenia
Q30712278Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
Q33833761Relationships between dorsolateral prefrontal cortex metabolic change and cognitive impairment in first-episode neuroleptic-naive schizophrenia patients.
Q59129268Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages
Q35096566Sleep spindles are related to schizotypal personality traits and thalamic glutamine/glutamate in healthy subjects
Q36469858Spectral fitting using basis set modified by measured B0 field distribution
Q41869167The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
Q38232366The neurobiology and treatment of first-episode schizophrenia

Search more.